Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

An interesting Provista brochure from June 2012 regarding LC Sentinel.

http://www.researchandmarkets.com/reports/1595832/provista_life_sciences_product_pipeline_analysis.pdf

Notice in the site description regarding product pipeline:

Provista Life Sciences (PLS) is a biopharmaceutical company, based in the US. The company designs, manufactures and markets -vitro diagnostic products. Its product portfolio includes BT test, RCP-Dx test and LymPro test. PLS BT Test is designed to assist physicians in making an earlier and more accurate diagnosis of breast cancer when used adjunctively with a mammogram. RCP-Dx Test is used to screen various types of cancers such as ovarian, breast, cervical and uterine cancers from a single blood sample. The company has completed extensive clinical trials on a new blood test for the early detection of breast cancer. PLS is headquartered in Phoenix, Arizona, the US.

The site address is: http://www.researchandmarkets.com/reports/1595832/provista_life_sciences_product_pipeline_analysis

It appears that good ol'e RCP is valuable to Provista after all.